Global Kidney Cancer Drugs Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Kidney Cancer Drugs Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Kidney Cancer Drugs by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Kidney Cancer Drugs by Country/Region, 2017, 2022 & 2028

2.2 Kidney Cancer Drugs Segment by Type

2.2.1 Angiogenesis Inhibitors

2.2.2 mTOR Inhibitors

2.2.3 Monoclonal Antibodies

2.2.4 Cytokine Immunotherapy (IL-2)

2.3 Kidney Cancer Drugs Sales by Type

2.3.1 Global Kidney Cancer Drugs Sales Market Share by Type (2017-2022)

2.3.2 Global Kidney Cancer Drugs Revenue and Market Share by Type (2017-2022)

2.3.3 Global Kidney Cancer Drugs Sale Price by Type (2017-2022)

2.4 Kidney Cancer Drugs Segment by Application

2.4.1 Renal Cell Carcinoma (RCC)

2.4.2 Transitional Cell Carcinoma (TCC)

2.5 Kidney Cancer Drugs Sales by Application

2.5.1 Global Kidney Cancer Drugs Sale Market Share by Application (2017-2022)

2.5.2 Global Kidney Cancer Drugs Revenue and Market Share by Application (2017-2022)

2.5.3 Global Kidney Cancer Drugs Sale Price by Application (2017-2022)

3 Global Kidney Cancer Drugs by Company

3.1 Global Kidney Cancer Drugs Breakdown Data by Company

3.1.1 Global Kidney Cancer Drugs Annual Sales by Company (2020-2022)

3.1.2 Global Kidney Cancer Drugs Sales Market Share by Company (2020-2022)

3.2 Global Kidney Cancer Drugs Annual Revenue by Company (2020-2022)

3.2.1 Global Kidney Cancer Drugs Revenue by Company (2020-2022)

3.2.2 Global Kidney Cancer Drugs Revenue Market Share by Company (2020-2022)

3.3 Global Kidney Cancer Drugs Sale Price by Company

3.4 Key Manufacturers Kidney Cancer Drugs Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Kidney Cancer Drugs Product Location Distribution

3.4.2 Players Kidney Cancer Drugs Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Kidney Cancer Drugs by Geographic Region

4.1 World Historic Kidney Cancer Drugs Market Size by Geographic Region (2017-2022)

4.1.1 Global Kidney Cancer Drugs Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Kidney Cancer Drugs Annual Revenue by Geographic Region

4.2 World Historic Kidney Cancer Drugs Market Size by Country/Region (2017-2022)

4.2.1 Global Kidney Cancer Drugs Annual Sales by Country/Region (2017-2022)

4.2.2 Global Kidney Cancer Drugs Annual Revenue by Country/Region

4.3 Americas Kidney Cancer Drugs Sales Growth

4.4 APAC Kidney Cancer Drugs Sales Growth

4.5 Europe Kidney Cancer Drugs Sales Growth

4.6 Middle East & Africa Kidney Cancer Drugs Sales Growth

5 Americas

5.1 Americas Kidney Cancer Drugs Sales by Country

5.1.1 Americas Kidney Cancer Drugs Sales by Country (2017-2022)

5.1.2 Americas Kidney Cancer Drugs Revenue by Country (2017-2022)

5.2 Americas Kidney Cancer Drugs Sales by Type

5.3 Americas Kidney Cancer Drugs Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Kidney Cancer Drugs Sales by Region

6.1.1 APAC Kidney Cancer Drugs Sales by Region (2017-2022)

6.1.2 APAC Kidney Cancer Drugs Revenue by Region (2017-2022)

6.2 APAC Kidney Cancer Drugs Sales by Type

6.3 APAC Kidney Cancer Drugs Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Kidney Cancer Drugs by Country

7.1.1 Europe Kidney Cancer Drugs Sales by Country (2017-2022)

7.1.2 Europe Kidney Cancer Drugs Revenue by Country (2017-2022)

7.2 Europe Kidney Cancer Drugs Sales by Type

7.3 Europe Kidney Cancer Drugs Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Kidney Cancer Drugs by Country

8.1.1 Middle East & Africa Kidney Cancer Drugs Sales by Country (2017-2022)

8.1.2 Middle East & Africa Kidney Cancer Drugs Revenue by Country (2017-2022)

8.2 Middle East & Africa Kidney Cancer Drugs Sales by Type

8.3 Middle East & Africa Kidney Cancer Drugs Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Kidney Cancer Drugs

10.3 Manufacturing Process Analysis of Kidney Cancer Drugs

10.4 Industry Chain Structure of Kidney Cancer Drugs

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Kidney Cancer Drugs Distributors

11.3 Kidney Cancer Drugs Customer

12 World Forecast Review for Kidney Cancer Drugs by Geographic Region

12.1 Global Kidney Cancer Drugs Market Size Forecast by Region

12.1.1 Global Kidney Cancer Drugs Forecast by Region (2023-2028)

12.1.2 Global Kidney Cancer Drugs Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Kidney Cancer Drugs Forecast by Type

12.7 Global Kidney Cancer Drugs Forecast by Application

13 Key Players Analysis

13.1 Bayer

13.1.1 Bayer Company Information

13.1.2 Bayer Kidney Cancer Drugs Product Offered

13.1.3 Bayer Kidney Cancer Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Bayer Main Business Overview

13.1.5 Bayer Latest Developments

13.2 Roche

13.2.1 Roche Company Information

13.2.2 Roche Kidney Cancer Drugs Product Offered

13.2.3 Roche Kidney Cancer Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Roche Main Business Overview

13.2.5 Roche Latest Developments

13.3 GlaxoSmithKline

13.3.1 GlaxoSmithKline Company Information

13.3.2 GlaxoSmithKline Kidney Cancer Drugs Product Offered

13.3.3 GlaxoSmithKline Kidney Cancer Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 GlaxoSmithKline Main Business Overview

13.3.5 GlaxoSmithKline Latest Developments

13.4 Novartis

13.4.1 Novartis Company Information

13.4.2 Novartis Kidney Cancer Drugs Product Offered

13.4.3 Novartis Kidney Cancer Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Novartis Main Business Overview

13.4.5 Novartis Latest Developments

13.5 Pfizer

13.5.1 Pfizer Company Information

13.5.2 Pfizer Kidney Cancer Drugs Product Offered

13.5.3 Pfizer Kidney Cancer Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Pfizer Main Business Overview

13.5.5 Pfizer Latest Developments

13.6 Abbott Laboratories

13.6.1 Abbott Laboratories Company Information

13.6.2 Abbott Laboratories Kidney Cancer Drugs Product Offered

13.6.3 Abbott Laboratories Kidney Cancer Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Abbott Laboratories Main Business Overview

13.6.5 Abbott Laboratories Latest Developments

13.7 Active Biotech

13.7.1 Active Biotech Company Information

13.7.2 Active Biotech Kidney Cancer Drugs Product Offered

13.7.3 Active Biotech Kidney Cancer Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Active Biotech Main Business Overview

13.7.5 Active Biotech Latest Developments

13.8 Amgen

13.8.1 Amgen Company Information

13.8.2 Amgen Kidney Cancer Drugs Product Offered

13.8.3 Amgen Kidney Cancer Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Amgen Main Business Overview

13.8.5 Amgen Latest Developments

13.9 Argos Therapeutics

13.9.1 Argos Therapeutics Company Information

13.9.2 Argos Therapeutics Kidney Cancer Drugs Product Offered

13.9.3 Argos Therapeutics Kidney Cancer Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Argos Therapeutics Main Business Overview

13.9.5 Argos Therapeutics Latest Developments

13.10 ArQule

13.10.1 ArQule Company Information

13.10.2 ArQule Kidney Cancer Drugs Product Offered

13.10.3 ArQule Kidney Cancer Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 ArQule Main Business Overview

13.10.5 ArQule Latest Developments

13.11 AVEO Pharmaceuticals

13.11.1 AVEO Pharmaceuticals Company Information

13.11.2 AVEO Pharmaceuticals Kidney Cancer Drugs Product Offered

13.11.3 AVEO Pharmaceuticals Kidney Cancer Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 AVEO Pharmaceuticals Main Business Overview

13.11.5 AVEO Pharmaceuticals Latest Developments

13.12 Bionomics

13.12.1 Bionomics Company Information

13.12.2 Bionomics Kidney Cancer Drugs Product Offered

13.12.3 Bionomics Kidney Cancer Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Bionomics Main Business Overview

13.12.5 Bionomics Latest Developments

13.13 Bristol-Myers Squibb

13.13.1 Bristol-Myers Squibb Company Information

13.13.2 Bristol-Myers Squibb Kidney Cancer Drugs Product Offered

13.13.3 Bristol-Myers Squibb Kidney Cancer Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 Bristol-Myers Squibb Main Business Overview

13.13.5 Bristol-Myers Squibb Latest Developments

13.14 Cerulean Pharma

13.14.1 Cerulean Pharma Company Information

13.14.2 Cerulean Pharma Kidney Cancer Drugs Product Offered

13.14.3 Cerulean Pharma Kidney Cancer Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.14.4 Cerulean Pharma Main Business Overview

13.14.5 Cerulean Pharma Latest Developments

13.15 Exelixis

13.15.1 Exelixis Company Information

13.15.2 Exelixis Kidney Cancer Drugs Product Offered

13.15.3 Exelixis Kidney Cancer Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.15.4 Exelixis Main Business Overview

13.15.5 Exelixis Latest Developments

13.16 Genentech

13.16.1 Genentech Company Information

13.16.2 Genentech Kidney Cancer Drugs Product Offered

13.16.3 Genentech Kidney Cancer Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.16.4 Genentech Main Business Overview

13.16.5 Genentech Latest Developments

13.17 immatics biotechnologies

13.17.1 immatics biotechnologies Company Information

13.17.2 immatics biotechnologies Kidney Cancer Drugs Product Offered

13.17.3 immatics biotechnologies Kidney Cancer Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.17.4 immatics biotechnologies Main Business Overview

13.17.5 immatics biotechnologies Latest Developments

13.18 Immunicum

13.18.1 Immunicum Company Information

13.18.2 Immunicum Kidney Cancer Drugs Product Offered

13.18.3 Immunicum Kidney Cancer Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.18.4 Immunicum Main Business Overview

13.18.5 Immunicum Latest Developments

13.19 Ono Pharmaceutical

13.19.1 Ono Pharmaceutical Company Information

13.19.2 Ono Pharmaceutical Kidney Cancer Drugs Product Offered

13.19.3 Ono Pharmaceutical Kidney Cancer Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.19.4 Ono Pharmaceutical Main Business Overview

13.19.5 Ono Pharmaceutical Latest Developments

13.20 Onyx Therapeutics

13.20.1 Onyx Therapeutics Company Information

13.20.2 Onyx Therapeutics Kidney Cancer Drugs Product Offered

13.20.3 Onyx Therapeutics Kidney Cancer Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.20.4 Onyx Therapeutics Main Business Overview

13.20.5 Onyx Therapeutics Latest Developments

13.21 Oxford BioMedica

13.21.1 Oxford BioMedica Company Information

13.21.2 Oxford BioMedica Kidney Cancer Drugs Product Offered

13.21.3 Oxford BioMedica Kidney Cancer Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.21.4 Oxford BioMedica Main Business Overview

13.21.5 Oxford BioMedica Latest Developments

13.22 Prometheus Laboratories

13.22.1 Prometheus Laboratories Company Information

13.22.2 Prometheus Laboratories Kidney Cancer Drugs Product Offered

13.22.3 Prometheus Laboratories Kidney Cancer Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.22.4 Prometheus Laboratories Main Business Overview

13.22.5 Prometheus Laboratories Latest Developments

13.23 Seattle Genetics

13.23.1 Seattle Genetics Company Information

13.23.2 Seattle Genetics Kidney Cancer Drugs Product Offered

13.23.3 Seattle Genetics Kidney Cancer Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.23.4 Seattle Genetics Main Business Overview

13.23.5 Seattle Genetics Latest Developments

13.24 Taiwan Liposome

13.24.1 Taiwan Liposome Company Information

13.24.2 Taiwan Liposome Kidney Cancer Drugs Product Offered

13.24.3 Taiwan Liposome Kidney Cancer Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.24.4 Taiwan Liposome Main Business Overview

13.24.5 Taiwan Liposome Latest Developments

13.25 Tracon Pharmaceuticals

13.25.1 Tracon Pharmaceuticals Company Information

13.25.2 Tracon Pharmaceuticals Kidney Cancer Drugs Product Offered

13.25.3 Tracon Pharmaceuticals Kidney Cancer Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.25.4 Tracon Pharmaceuticals Main Business Overview

13.25.5 Tracon Pharmaceuticals Latest Developments

13.26 Wilex

13.26.1 Wilex Company Information

13.26.2 Wilex Kidney Cancer Drugs Product Offered

13.26.3 Wilex Kidney Cancer Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.26.4 Wilex Main Business Overview

13.26.5 Wilex Latest Developments

14 Research Findings and Conclusion

Table 1. Kidney Cancer Drugs Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Kidney Cancer Drugs Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Angiogenesis Inhibitors

Table 4. Major Players of mTOR Inhibitors

Table 5. Major Players of Monoclonal Antibodies

Table 6. Major Players of Cytokine Immunotherapy (IL-2)

Table 7. Global Kidney Cancer Drugs Sales by Type (2017-2022) & (K Units)

Table 8. Global Kidney Cancer Drugs Sales Market Share by Type (2017-2022)

Table 9. Global Kidney Cancer Drugs Revenue by Type (2017-2022) & ($ million)

Table 10. Global Kidney Cancer Drugs Revenue Market Share by Type (2017-2022)

Table 11. Global Kidney Cancer Drugs Sale Price by Type (2017-2022) & (USD/Unit)

Table 12. Global Kidney Cancer Drugs Sales by Application (2017-2022) & (K Units)

Table 13. Global Kidney Cancer Drugs Sales Market Share by Application (2017-2022)

Table 14. Global Kidney Cancer Drugs Revenue by Application (2017-2022)

Table 15. Global Kidney Cancer Drugs Revenue Market Share by Application (2017-2022)

Table 16. Global Kidney Cancer Drugs Sale Price by Application (2017-2022) & (USD/Unit)

Table 17. Global Kidney Cancer Drugs Sales by Company (2020-2022) & (K Units)

Table 18. Global Kidney Cancer Drugs Sales Market Share by Company (2020-2022)

Table 19. Global Kidney Cancer Drugs Revenue by Company (2020-2022) ($ Millions)

Table 20. Global Kidney Cancer Drugs Revenue Market Share by Company (2020-2022)

Table 21. Global Kidney Cancer Drugs Sale Price by Company (2020-2022) & (USD/Unit)

Table 22. Key Manufacturers Kidney Cancer Drugs Producing Area Distribution and Sales Area

Table 23. Players Kidney Cancer Drugs Products Offered

Table 24. Kidney Cancer Drugs Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 25. New Products and Potential Entrants

Table 26. Mergers & Acquisitions, Expansion

Table 27. Global Kidney Cancer Drugs Sales by Geographic Region (2017-2022) & (K Units)

Table 28. Global Kidney Cancer Drugs Sales Market Share Geographic Region (2017-2022)

Table 29. Global Kidney Cancer Drugs Revenue by Geographic Region (2017-2022) & ($ millions)

Table 30. Global Kidney Cancer Drugs Revenue Market Share by Geographic Region (2017-2022)

Table 31. Global Kidney Cancer Drugs Sales by Country/Region (2017-2022) & (K Units)

Table 32. Global Kidney Cancer Drugs Sales Market Share by Country/Region (2017-2022)

Table 33. Global Kidney Cancer Drugs Revenue by Country/Region (2017-2022) & ($ millions)

Table 34. Global Kidney Cancer Drugs Revenue Market Share by Country/Region (2017-2022)

Table 35. Americas Kidney Cancer Drugs Sales by Country (2017-2022) & (K Units)

Table 36. Americas Kidney Cancer Drugs Sales Market Share by Country (2017-2022)

Table 37. Americas Kidney Cancer Drugs Revenue by Country (2017-2022) & ($ Millions)

Table 38. Americas Kidney Cancer Drugs Revenue Market Share by Country (2017-2022)

Table 39. Americas Kidney Cancer Drugs Sales by Type (2017-2022) & (K Units)

Table 40. Americas Kidney Cancer Drugs Sales Market Share by Type (2017-2022)

Table 41. Americas Kidney Cancer Drugs Sales by Application (2017-2022) & (K Units)

Table 42. Americas Kidney Cancer Drugs Sales Market Share by Application (2017-2022)

Table 43. APAC Kidney Cancer Drugs Sales by Region (2017-2022) & (K Units)

Table 44. APAC Kidney Cancer Drugs Sales Market Share by Region (2017-2022)

Table 45. APAC Kidney Cancer Drugs Revenue by Region (2017-2022) & ($ Millions)

Table 46. APAC Kidney Cancer Drugs Revenue Market Share by Region (2017-2022)

Table 47. APAC Kidney Cancer Drugs Sales by Type (2017-2022) & (K Units)

Table 48. APAC Kidney Cancer Drugs Sales Market Share by Type (2017-2022)

Table 49. APAC Kidney Cancer Drugs Sales by Application (2017-2022) & (K Units)

Table 50. APAC Kidney Cancer Drugs Sales Market Share by Application (2017-2022)

Table 51. Europe Kidney Cancer Drugs Sales by Country (2017-2022) & (K Units)

Table 52. Europe Kidney Cancer Drugs Sales Market Share by Country (2017-2022)

Table 53. Europe Kidney Cancer Drugs Revenue by Country (2017-2022) & ($ Millions)

Table 54. Europe Kidney Cancer Drugs Revenue Market Share by Country (2017-2022)

Table 55. Europe Kidney Cancer Drugs Sales by Type (2017-2022) & (K Units)

Table 56. Europe Kidney Cancer Drugs Sales Market Share by Type (2017-2022)

Table 57. Europe Kidney Cancer Drugs Sales by Application (2017-2022) & (K Units)

Table 58. Europe Kidney Cancer Drugs Sales Market Share by Application (2017-2022)

Table 59. Middle East & Africa Kidney Cancer Drugs Sales by Country (2017-2022) & (K Units)

Table 60. Middle East & Africa Kidney Cancer Drugs Sales Market Share by Country (2017-2022)

Table 61. Middle East & Africa Kidney Cancer Drugs Revenue by Country (2017-2022) & ($ Millions)

Table 62. Middle East & Africa Kidney Cancer Drugs Revenue Market Share by Country (2017-2022)

Table 63. Middle East & Africa Kidney Cancer Drugs Sales by Type (2017-2022) & (K Units)

Table 64. Middle East & Africa Kidney Cancer Drugs Sales Market Share by Type (2017-2022)

Table 65. Middle East & Africa Kidney Cancer Drugs Sales by Application (2017-2022) & (K Units)

Table 66. Middle East & Africa Kidney Cancer Drugs Sales Market Share by Application (2017-2022)

Table 67. Key Market Drivers & Growth Opportunities of Kidney Cancer Drugs

Table 68. Key Market Challenges & Risks of Kidney Cancer Drugs

Table 69. Key Industry Trends of Kidney Cancer Drugs

Table 70. Kidney Cancer Drugs Raw Material

Table 71. Key Suppliers of Raw Materials

Table 72. Kidney Cancer Drugs Distributors List

Table 73. Kidney Cancer Drugs Customer List

Table 74. Global Kidney Cancer Drugs Sales Forecast by Region (2023-2028) & (K Units)

Table 75. Global Kidney Cancer Drugs Sales Market Forecast by Region

Table 76. Global Kidney Cancer Drugs Revenue Forecast by Region (2023-2028) & ($ millions)

Table 77. Global Kidney Cancer Drugs Revenue Market Share Forecast by Region (2023-2028)

Table 78. Americas Kidney Cancer Drugs Sales Forecast by Country (2023-2028) & (K Units)

Table 79. Americas Kidney Cancer Drugs Revenue Forecast by Country (2023-2028) & ($ millions)

Table 80. APAC Kidney Cancer Drugs Sales Forecast by Region (2023-2028) & (K Units)

Table 81. APAC Kidney Cancer Drugs Revenue Forecast by Region (2023-2028) & ($ millions)

Table 82. Europe Kidney Cancer Drugs Sales Forecast by Country (2023-2028) & (K Units)

Table 83. Europe Kidney Cancer Drugs Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Middle East & Africa Kidney Cancer Drugs Sales Forecast by Country (2023-2028) & (K Units)

Table 85. Middle East & Africa Kidney Cancer Drugs Revenue Forecast by Country (2023-2028) & ($ millions)

Table 86. Global Kidney Cancer Drugs Sales Forecast by Type (2023-2028) & (K Units)

Table 87. Global Kidney Cancer Drugs Sales Market Share Forecast by Type (2023-2028)

Table 88. Global Kidney Cancer Drugs Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 89. Global Kidney Cancer Drugs Revenue Market Share Forecast by Type (2023-2028)

Table 90. Global Kidney Cancer Drugs Sales Forecast by Application (2023-2028) & (K Units)

Table 91. Global Kidney Cancer Drugs Sales Market Share Forecast by Application (2023-2028)

Table 92. Global Kidney Cancer Drugs Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 93. Global Kidney Cancer Drugs Revenue Market Share Forecast by Application (2023-2028)

Table 94. Bayer Basic Information, Kidney Cancer Drugs Manufacturing Base, Sales Area and Its Competitors

Table 95. Bayer Kidney Cancer Drugs Product Offered

Table 96. Bayer Kidney Cancer Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 97. Bayer Main Business

Table 98. Bayer Latest Developments

Table 99. Roche Basic Information, Kidney Cancer Drugs Manufacturing Base, Sales Area and Its Competitors

Table 100. Roche Kidney Cancer Drugs Product Offered

Table 101. Roche Kidney Cancer Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 102. Roche Main Business

Table 103. Roche Latest Developments

Table 104. GlaxoSmithKline Basic Information, Kidney Cancer Drugs Manufacturing Base, Sales Area and Its Competitors

Table 105. GlaxoSmithKline Kidney Cancer Drugs Product Offered

Table 106. GlaxoSmithKline Kidney Cancer Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 107. GlaxoSmithKline Main Business

Table 108. GlaxoSmithKline Latest Developments

Table 109. Novartis Basic Information, Kidney Cancer Drugs Manufacturing Base, Sales Area and Its Competitors

Table 110. Novartis Kidney Cancer Drugs Product Offered

Table 111. Novartis Kidney Cancer Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 112. Novartis Main Business

Table 113. Novartis Latest Developments

Table 114. Pfizer Basic Information, Kidney Cancer Drugs Manufacturing Base, Sales Area and Its Competitors

Table 115. Pfizer Kidney Cancer Drugs Product Offered

Table 116. Pfizer Kidney Cancer Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 117. Pfizer Main Business

Table 118. Pfizer Latest Developments

Table 119. Abbott Laboratories Basic Information, Kidney Cancer Drugs Manufacturing Base, Sales Area and Its Competitors

Table 120. Abbott Laboratories Kidney Cancer Drugs Product Offered

Table 121. Abbott Laboratories Kidney Cancer Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 122. Abbott Laboratories Main Business

Table 123. Abbott Laboratories Latest Developments

Table 124. Active Biotech Basic Information, Kidney Cancer Drugs Manufacturing Base, Sales Area and Its Competitors

Table 125. Active Biotech Kidney Cancer Drugs Product Offered

Table 126. Active Biotech Kidney Cancer Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 127. Active Biotech Main Business

Table 128. Active Biotech Latest Developments

Table 129. Amgen Basic Information, Kidney Cancer Drugs Manufacturing Base, Sales Area and Its Competitors

Table 130. Amgen Kidney Cancer Drugs Product Offered

Table 131. Amgen Kidney Cancer Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 132. Amgen Main Business

Table 133. Amgen Latest Developments

Table 134. Argos Therapeutics Basic Information, Kidney Cancer Drugs Manufacturing Base, Sales Area and Its Competitors

Table 135. Argos Therapeutics Kidney Cancer Drugs Product Offered

Table 136. Argos Therapeutics Kidney Cancer Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 137. Argos Therapeutics Main Business

Table 138. Argos Therapeutics Latest Developments

Table 139. ArQule Basic Information, Kidney Cancer Drugs Manufacturing Base, Sales Area and Its Competitors

Table 140. ArQule Kidney Cancer Drugs Product Offered

Table 141. ArQule Kidney Cancer Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 142. ArQule Main Business

Table 143. ArQule Latest Developments

Table 144. AVEO Pharmaceuticals Basic Information, Kidney Cancer Drugs Manufacturing Base, Sales Area and Its Competitors

Table 145. AVEO Pharmaceuticals Kidney Cancer Drugs Product Offered

Table 146. AVEO Pharmaceuticals Kidney Cancer Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 147. AVEO Pharmaceuticals Main Business

Table 148. AVEO Pharmaceuticals Latest Developments

Table 149. Bionomics Basic Information, Kidney Cancer Drugs Manufacturing Base, Sales Area and Its Competitors

Table 150. Bionomics Kidney Cancer Drugs Product Offered

Table 151. Bionomics Kidney Cancer Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 152. Bionomics Main Business

Table 153. Bionomics Latest Developments

Table 154. Bristol-Myers Squibb Basic Information, Kidney Cancer Drugs Manufacturing Base, Sales Area and Its Competitors

Table 155. Bristol-Myers Squibb Kidney Cancer Drugs Product Offered

Table 156. Bristol-Myers Squibb Kidney Cancer Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 157. Bristol-Myers Squibb Main Business

Table 158. Bristol-Myers Squibb Latest Developments

Table 159. Cerulean Pharma Basic Information, Kidney Cancer Drugs Manufacturing Base, Sales Area and Its Competitors

Table 160. Cerulean Pharma Kidney Cancer Drugs Product Offered

Table 161. Cerulean Pharma Kidney Cancer Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 162. Cerulean Pharma Main Business

Table 163. Cerulean Pharma Latest Developments

Table 164. Exelixis Basic Information, Kidney Cancer Drugs Manufacturing Base, Sales Area and Its Competitors

Table 165. Exelixis Kidney Cancer Drugs Product Offered

Table 166. Exelixis Kidney Cancer Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 167. Exelixis Main Business

Table 168. Exelixis Latest Developments

Table 169. Genentech Basic Information, Kidney Cancer Drugs Manufacturing Base, Sales Area and Its Competitors

Table 170. Genentech Kidney Cancer Drugs Product Offered

Table 171. Genentech Kidney Cancer Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 172. Genentech Main Business

Table 173. Genentech Latest Developments

Table 174. immatics biotechnologies Basic Information, Kidney Cancer Drugs Manufacturing Base, Sales Area and Its Competitors

Table 175. immatics biotechnologies Kidney Cancer Drugs Product Offered

Table 176. immatics biotechnologies Kidney Cancer Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 177. immatics biotechnologies Main Business

Table 178. immatics biotechnologies Latest Developments

Table 179. Immunicum Basic Information, Kidney Cancer Drugs Manufacturing Base, Sales Area and Its Competitors

Table 180. Immunicum Kidney Cancer Drugs Product Offered

Table 181. Immunicum Kidney Cancer Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 182. Immunicum Main Business

Table 183. Immunicum Latest Developments

Table 184. Ono Pharmaceutical Basic Information, Kidney Cancer Drugs Manufacturing Base, Sales Area and Its Competitors

Table 185. Ono Pharmaceutical Kidney Cancer Drugs Product Offered

Table 186. Ono Pharmaceutical Kidney Cancer Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 187. Ono Pharmaceutical Main Business

Table 188. Ono Pharmaceutical Latest Developments

Table 189. Onyx Therapeutics Basic Information, Kidney Cancer Drugs Manufacturing Base, Sales Area and Its Competitors

Table 190. Onyx Therapeutics Kidney Cancer Drugs Product Offered

Table 191. Onyx Therapeutics Kidney Cancer Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 192. Onyx Therapeutics Main Business

Table 193. Onyx Therapeutics Latest Developments

Table 194. Oxford BioMedica Basic Information, Kidney Cancer Drugs Manufacturing Base, Sales Area and Its Competitors

Table 195. Oxford BioMedica Kidney Cancer Drugs Product Offered

Table 196. Oxford BioMedica Kidney Cancer Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 197. Oxford BioMedica Main Business

Table 198. Oxford BioMedica Latest Developments

Table 199. Prometheus Laboratories Basic Information, Kidney Cancer Drugs Manufacturing Base, Sales Area and Its Competitors

Table 200. Prometheus Laboratories Kidney Cancer Drugs Product Offered

Table 201. Prometheus Laboratories Kidney Cancer Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 202. Prometheus Laboratories Main Business

Table 203. Prometheus Laboratories Latest Developments

Table 204. Seattle Genetics Basic Information, Kidney Cancer Drugs Manufacturing Base, Sales Area and Its Competitors

Table 205. Seattle Genetics Kidney Cancer Drugs Product Offered

Table 206. Seattle Genetics Kidney Cancer Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 207. Seattle Genetics Main Business

Table 208. Seattle Genetics Latest Developments

Table 209. Taiwan Liposome Basic Information, Kidney Cancer Drugs Manufacturing Base, Sales Area and Its Competitors

Table 210. Taiwan Liposome Kidney Cancer Drugs Product Offered

Table 211. Taiwan Liposome Kidney Cancer Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 212. Taiwan Liposome Main Business

Table 213. Taiwan Liposome Latest Developments

Table 214. Tracon Pharmaceuticals Basic Information, Kidney Cancer Drugs Manufacturing Base, Sales Area and Its Competitors

Table 215. Tracon Pharmaceuticals Kidney Cancer Drugs Product Offered

Table 216. Tracon Pharmaceuticals Kidney Cancer Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 217. Tracon Pharmaceuticals Main Business

Table 218. Tracon Pharmaceuticals Latest Developments

Table 219. Wilex Basic Information, Kidney Cancer Drugs Manufacturing Base, Sales Area and Its Competitors

Table 220. Wilex Kidney Cancer Drugs Product Offered

Table 221. Wilex Kidney Cancer Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 222. Wilex Main Business

Table 223. Wilex Latest Developments

List of Figures

Figure 1. Picture of Kidney Cancer Drugs

Figure 2. Kidney Cancer Drugs Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Kidney Cancer Drugs Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Kidney Cancer Drugs Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Kidney Cancer Drugs Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Angiogenesis Inhibitors

Figure 10. Product Picture of mTOR Inhibitors

Figure 11. Product Picture of Monoclonal Antibodies

Figure 12. Product Picture of Cytokine Immunotherapy (IL-2)

Figure 13. Global Kidney Cancer Drugs Sales Market Share by Type in 2021

Figure 14. Global Kidney Cancer Drugs Revenue Market Share by Type (2017-2022)

Figure 15. Kidney Cancer Drugs Consumed in Renal Cell Carcinoma (RCC)

Figure 16. Global Kidney Cancer Drugs Market: Renal Cell Carcinoma (RCC) (2017-2022) & (K Units)

Figure 17. Kidney Cancer Drugs Consumed in Transitional Cell Carcinoma (TCC)

Figure 18. Global Kidney Cancer Drugs Market: Transitional Cell Carcinoma (TCC) (2017-2022) & (K Units)

Figure 19. Global Kidney Cancer Drugs Sales Market Share by Application (2017-2022)

Figure 20. Global Kidney Cancer Drugs Revenue Market Share by Application in 2021

Figure 21. Kidney Cancer Drugs Revenue Market by Company in 2021 ($ Million)

Figure 22. Global Kidney Cancer Drugs Revenue Market Share by Company in 2021

Figure 23. Global Kidney Cancer Drugs Sales Market Share by Geographic Region (2017-2022)

Figure 24. Global Kidney Cancer Drugs Revenue Market Share by Geographic Region in 2021

Figure 25. Global Kidney Cancer Drugs Sales Market Share by Region (2017-2022)

Figure 26. Global Kidney Cancer Drugs Revenue Market Share by Country/Region in 2021

Figure 27. Americas Kidney Cancer Drugs Sales 2017-2022 (K Units)

Figure 28. Americas Kidney Cancer Drugs Revenue 2017-2022 ($ Millions)

Figure 29. APAC Kidney Cancer Drugs Sales 2017-2022 (K Units)

Figure 30. APAC Kidney Cancer Drugs Revenue 2017-2022 ($ Millions)

Figure 31. Europe Kidney Cancer Drugs Sales 2017-2022 (K Units)

Figure 32. Europe Kidney Cancer Drugs Revenue 2017-2022 ($ Millions)

Figure 33. Middle East & Africa Kidney Cancer Drugs Sales 2017-2022 (K Units)

Figure 34. Middle East & Africa Kidney Cancer Drugs Revenue 2017-2022 ($ Millions)

Figure 35. Americas Kidney Cancer Drugs Sales Market Share by Country in 2021

Figure 36. Americas Kidney Cancer Drugs Revenue Market Share by Country in 2021

Figure 37. United States Kidney Cancer Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 38. Canada Kidney Cancer Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 39. Mexico Kidney Cancer Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 40. Brazil Kidney Cancer Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 41. APAC Kidney Cancer Drugs Sales Market Share by Region in 2021

Figure 42. APAC Kidney Cancer Drugs Revenue Market Share by Regions in 2021

Figure 43. China Kidney Cancer Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 44. Japan Kidney Cancer Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 45. South Korea Kidney Cancer Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 46. Southeast Asia Kidney Cancer Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 47. India Kidney Cancer Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 48. Australia Kidney Cancer Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 49. Europe Kidney Cancer Drugs Sales Market Share by Country in 2021

Figure 50. Europe Kidney Cancer Drugs Revenue Market Share by Country in 2021

Figure 51. Germany Kidney Cancer Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 52. France Kidney Cancer Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 53. UK Kidney Cancer Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 54. Italy Kidney Cancer Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 55. Russia Kidney Cancer Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 56. Middle East & Africa Kidney Cancer Drugs Sales Market Share by Country in 2021

Figure 57. Middle East & Africa Kidney Cancer Drugs Revenue Market Share by Country in 2021

Figure 58. Egypt Kidney Cancer Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 59. South Africa Kidney Cancer Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 60. Israel Kidney Cancer Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 61. Turkey Kidney Cancer Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 62. GCC Country Kidney Cancer Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 63. Manufacturing Cost Structure Analysis of Kidney Cancer Drugs in 2021

Figure 64. Manufacturing Process Analysis of Kidney Cancer Drugs

Figure 65. Industry Chain Structure of Kidney Cancer Drugs

Figure 66. Channels of Distribution

Figure 67. Distributors Profiles